Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2017

01-04-2017 | Editorial

The High and Rising Costs of Obesity to the US Health Care System

Authors: Adam Biener, PhD, John Cawley, PhD, Chad Meyerhoefer, PhD

Published in: Journal of General Internal Medicine | Special Issue 1/2017

Login to get access

Excerpt

The papers in this special issue examine behavioral, pharmacotherapy, and surgical interventions for weight loss, based on a 2016 conference on state-of-the-art weight management hosted by the Veterans Health Administration. The purpose of this editorial is to provide new information on the medical care costs of obesity that help motivate those interventions. …
Literature
1.
go back to reference Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–30.CrossRefPubMed Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–30.CrossRefPubMed
2.
go back to reference Cawley J, Meyerhoefer C, Biener A, Hammer M, Wintfeld N. Savings in medical expenditures associated with reductions in body mass index among adults with obesity, by diabetes status. Pharmacoeconomics. 2015;33:707–22.CrossRefPubMed Cawley J, Meyerhoefer C, Biener A, Hammer M, Wintfeld N. Savings in medical expenditures associated with reductions in body mass index among adults with obesity, by diabetes status. Pharmacoeconomics. 2015;33:707–22.CrossRefPubMed
3.
go back to reference Specifically, we estimated two-part IV models of health care costs in which the BMI of a biological child serves as an instrument for the BMI of the adult MEPS respondent. Given the nature of the instrument, the MEPS sample is limited to adults who have a biological child living in their household. The age restriction for adults is 20-64 years and that for biological children is 11-20 years. For more details on the models and data, please see Cawley and Meyerhoefer (2012) and Cawley, Meyerhoefer, and Biener (2015). Specifically, we estimated two-part IV models of health care costs in which the BMI of a biological child serves as an instrument for the BMI of the adult MEPS respondent. Given the nature of the instrument, the MEPS sample is limited to adults who have a biological child living in their household. The age restriction for adults is 20-64 years and that for biological children is 11-20 years.  For more details on the models and data, please see Cawley and Meyerhoefer (2012) and Cawley, Meyerhoefer, and Biener (2015).
4.
go back to reference Funk LM, Gunnar W, Eisenberg D, et al. A health services research agenda for bariatric surgery within the Veterans Health Administration. This issue. Funk LM, Gunnar W, Eisenberg D, et al. A health services research agenda for bariatric surgery within the Veterans Health Administration. This issue.
6.
go back to reference Cawley J. An economy of scales: a selective review of obesity’s economic causes, consequences, and solutions. J Health Econ. 2015;43:244–68.CrossRefPubMed Cawley J. An economy of scales: a selective review of obesity’s economic causes, consequences, and solutions. J Health Econ. 2015;43:244–68.CrossRefPubMed
7.
go back to reference Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–48.CrossRefPubMedPubMedCentral Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–48.CrossRefPubMedPubMedCentral
8.
go back to reference Cawley J, Maclean JC, Hammer M, Wintfeld N. Reporting error in weight and its implications for estimates of the economic consequences of obesity. Econ Human Biol. 2015;19:27–44.CrossRef Cawley J, Maclean JC, Hammer M, Wintfeld N. Reporting error in weight and its implications for estimates of the economic consequences of obesity. Econ Human Biol. 2015;19:27–44.CrossRef
Metadata
Title
The High and Rising Costs of Obesity to the US Health Care System
Authors
Adam Biener, PhD
John Cawley, PhD
Chad Meyerhoefer, PhD
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue Special Issue 1/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3968-8

Other articles of this Special Issue 1/2017

Journal of General Internal Medicine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.